HIGHLIGHTS
- who: Ling Ding and colleagues from the Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, China have published the research: Bufalin Inhibits Tumorigenesis, Stemness, and Epithelial-Mesenchymal Transition in Colorectal Cancer through a C-Kit/Slug Signaling Axis, in the Journal: (JOURNAL) of 11/Oct/2022
- what: Diethylaminobenzaldehyde (DEAB), which can inhibit the activity 5 of 19 of ALDH, was used as a negative control to obtain background readings. The authors used PDOs to further explore the efficacy of bufalin against CRC and the role of C-Kit/Slug signaling pathway. All . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.